Here, we focused on CDA1, which was significantly decreased in human IPF, in a mouse model of bleomycin (BLM)-induced PF, and in transforming growth factor (TGF-β)-challenged lung fibroblasts. This evidence concerns the gene TSPYL2 and idiopathic pulmonary fibrosis.